TTRX
Turn Therapeutics Inc. Common Stock (TTRX)
Healthcare • NASDAQ • $3.79-0.13%
- Symbol
- TTRX
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $3.79
- Daily Change
- -0.13%
- Market Cap
- $112.89M
- Trailing P/E
- N/A
- Forward P/E
- -25.27
- 52W High
- $26.50
- 52W Low
- $2.57
- Analyst Target
- $8.00
- Dividend Yield
- N/A
- Beta
- N/A
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Company websiteResearch TTRX on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.